- Notification that Annual Report will be submitted late (NT 10-K)
29 Januar 2010 - 7:56PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, DC
20549
FORM 12b-25
SEC File
Number: 000-28761
CUSIP
Number: 14160X 104
NOTIFICATION OF LATE
FILING
(Check One):
|
x
Form 10-K
o
Form 20-F
o
Form 11-K
o
Form 10-Q
o
Form N-SAR
o
Form N-CSR
|
|
|
|
For Period Ended:
Fiscal Year ended
October 31, 2009
|
|
|
|
o
Transition Report on Form
10-K
|
|
o
Transition Report on Form
20-F
|
|
o
Transition Report on Form
11-K
|
|
o
Transition Report on Form
10-Q
|
|
o
Transition Report on Form
N-SAR
|
|
|
|
For
the Transition Period Ended:
________________________
|
Read
attached instruction sheet before preparing form. Please print or
type.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained
herein.
|
If the
notification relates to a portion of the filing checked above, identify the
item(s) to which the notification relates:
______________________________________________________________________________
PART I -- REGISTRANT
INFORMATION
CardioGenics Holdings
Inc.
Full name
of registrant:
Former
name if applicable:
6295
Northam Drive, Unit 8
Address
of principal executive office (Street and number):
Mississauga,
Ontario L4V 1WB
City,
state and zip code
PART II -- RULES 12b-25(b) AND
(c)
If the
subject report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate.)
x
|
(a)
|
The
reasons described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or expense;
|
|
|
|
x
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K,
Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or
before the fifteenth calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form 10-Q, or portion
thereof will be filed on or before the fifth calendar day following the
prescribed due date; and
|
|
|
|
|
(c)
|
The
accountant's statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
PART III --
NARRATIVE
State below in reasonable detail the
reasons why Forms 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion
thereof could not be filed within the prescribed time period. (Attach
extra sheets if needed).
Records
and documentation necessary for completion of the narrative and financial
statements for the report were not available in time to complete the Form 10-K
of the Registrant for the fiscal year ending October 31, 2009. The
Registrant will file such report on or before February 15, 20010.
PART IV -- OTHER
INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
|
Yahia
Gawad
|
|
(905)
|
|
673-8501
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone
Number)
|
(2)
|
Have all other periodic reports
required under Section 13 or 15(d) of the Securities Exchange Act of 1934
or Section 30 of the Investment Company Act of 1940 during the preceding
12 months or for such shorter period that the registrant was required to
file such report(s) been filed? If the answer is no, identify report(s).
|
|
|
|
x
Yes
o
No
|
|
|
(3)
|
Is it anticipated that any
significant change in results of operations from the corresponding period
for the last fiscal year will be reflected by the earnings statements to
be included in the subject report or portion thereof?
|
|
|
|
o
Yes
x
No
|
If so,
attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
CardioGenics Holdings
Inc.
(Name of
Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
Date:
January 29,
2009
|
By:
|
/s/ Yahia Gawad
|
|
|
|
Title:
Chief Executive
Officer
|
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
Von Jul 2023 bis Jul 2024